Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  

PCSK9 inhibitors

Mariusz Kruk: Plaque-Directed Intervention for the Prevention of Myocardial Infarction
Aug 21, 2026, 15:26 | Voices
Mariusz Kruk: Plaque-Directed Intervention for the Prevention of Myocardial Infarction
Mariusz Kruk, Professor at National Institute of Cardiology, shared Alejandro González Veliz's shared post on…
Thomas Dayspring։ Could PCSK9 Inhibitors Reduce the Risk of Retinal Vascular Occlusions?
Jul 27, 2026, 16:57 | Science
Thomas Dayspring։ Could PCSK9 Inhibitors Reduce the Risk of Retinal Vascular Occlusions?
Thomas Dayspring, Lipid Specialist, Educator at Early Medical, shared a post on LinkedIn about a…
Raul Santos: Why Does LDL-C Remain Elevated in Many Patients?
Jul 2, 2026, 15:59 | Science
Raul Santos: Why Does LDL-C Remain Elevated in Many Patients?
Raul Santos, Researcher at ARO Hospital Israelita Albert Einstein, shared on LinkedIn about a recent…
Akinchan Bhardwaj: Key Genomic Insights Transforming Coronary Artery Disease Prevention
Mar 2, 2026, 10:48 | Science
Akinchan Bhardwaj: Key Genomic Insights Transforming Coronary Artery Disease Prevention
Akinchan Bhardwaj, Consultant Interventional Cardiologist at Kauvery Hospital, shared a post on LinkedIn about a recent…
Federica Fogacci on Sex Differences in Inflammatory Markers During Extended Evolocumab Treatment
Dec 3, 2025, 04:36 | Science
Federica Fogacci on Sex Differences in Inflammatory Markers During Extended Evolocumab Treatment
Federica Fogacci, Young Fellow at European Atherosclerosis Society, shared on LinkedIn: ''Large outcome trials have…
Paolo Calabrò: Lower LDL-C Variability With PCSK9 Inhibitors and Inclisira
Nov 25, 2025, 09:08 | Science
Paolo Calabrò: Lower LDL-C Variability With PCSK9 Inhibitors and Inclisira
Paolo Calabrò, Director of the Cardiovascular Department at S. Anna and S. Sebastiano Hospital, shared…
Matias Arrupe: The Value of Lipoprotein(a) in Reclassifying Cardiovascular Risk
Nov 19, 2025, 13:39 | Science
Matias Arrupe: The Value of Lipoprotein(a) in Reclassifying Cardiovascular Risk
Matias Arrupe, Cardiologist at CardioInnova Medical Research, shared on LinkedIn: ”Reclassifying Cardiovascular Risk with a Simple…
Ahmed Bennis on Use of Evolocumab in Patients without a Previous MI or Stroke
Nov 16, 2025, 19:50 | Science
Ahmed Bennis on Use of Evolocumab in Patients without a Previous MI or Stroke
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared on LinkedIn: ''First favorite…
Davide Capodanno Shares FITTER Trial: Evolocumab Shows No Added Short-Term Benefit in Acute Coronary Syndrome
Aug 18, 2025, 23:54 | Science
Davide Capodanno Shares FITTER Trial: Evolocumab Shows No Added Short-Term Benefit in Acute Coronary Syndrome
Davide Capodanno, professor of Cardiology at University of Catania, editor-in-Chief of EuroIntervention, posted on X:…
All: 9 Posts: 1 - 100
NewsFeed